Low levels of HDL cholesterol and having two or more components of metabolic syndrome predict recurrence
Read More »Long-Term Complications Common With Youth-Onset T2DM
Risk factors for development of complications include minority race or ethnic group, hyperglycemia, hypertension, dyslipidemia
Read More »FDA Approves First Biosimilar Insulin Product
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Read More »DoD Not Protecting Service Members From Toxic ‘Forever Chemicals’: Audit
Audit also noted that department is falling short on tracking the health effects from exposure to perfluoroalkyl and polyfluoroalkyl substances
Read More »Better Strategies Needed for Managing NAFLD in Adults
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
Read More »Antidepressant Use May Aid Outcomes in Depression and Diabetes
Regular versus poor antidepressant use tied to lower risk for advanced diabetic complications, mortality in patients with depression and diabetes
Read More »No Increase in Risk With Dapagliflozin in Patients With Stage 4 CKD
Prespecified analysis of RCT shows reduced risk with dapagliflozin versus placebo for composite outcome that included kidney, CV events
Read More »Cycling Linked to Reduced All-Cause, CVD Mortality in Diabetes
Multivariable-adjusted hazard ratios for all-cause mortality reduced for one to 59, 60 to 149, 150 to 299, and ≥300 minutes/week
Read More »Testosterone Therapy for Hypogonadism May Cut Risk for CV Events
Risk for myocardial infarction or stroke lower with testosterone therapy among men with hypogonadism and other cardiovascular risk factors
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.